Correlation of epidermal growth factor receptor with morphological features of colorectal advanced adenomas: A pilot correlative case series

American Journal of the Medical Sciences

Volumn 340, Issue 4, 2010, Pages 296-300

  Bansal, Ajay ^a   Liu, Xiaoying ^a   McGregor, Douglas H ^a   Singh, Vikas ^a   Hall, Sandy ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

Colorectal adenomas; EGFR; Epidermal growth factor receptor

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; ADVANCED CANCER; ARTICLE; CANCER MORPHOLOGY; CLINICAL ARTICLE; COLON MUCOSA; COLORECTAL ADENOMA; CONTROLLED STUDY; HUMAN; IMMUNOHISTOCHEMISTRY; IRON DEFICIENCY ANEMIA; MALE; PROTEIN EXPRESSION; TUMOR VOLUME;

EID: 77957978081     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3181e7fbf3     Document Type: Article

References (20)

1. Jonker DJ, O'Callaghan CJ, Karapetis CS, et al. Cetuximab for the treatment of colorectal cancer. N Engl J Med 2007;357:2040-2048
2. Dougherty U, Sehdev A, Cerda S, et al. Epidermal growth factor receptor controls flat dysplastic aberrant crypt foci development and colon cancer progression in the rat azoxymethane model. Clin Cancer Res 2008;14:2253-2262
3. Koretz K, Schlag P, Moller P. Expression of epidermal growth factor receptor in normal colorectal mucosa, adenoma, and carcinoma. Virchows Arch A Pathol Anat Histopathol 1990;416:343-349
4. Bhargava R, Chen B, Klimstra DS, et al. Comparison of two antibodies for immunohistochemical evaluation of epidermal growth factor receptor expression in colorectal carcinomas, adenomas, and normal mucosa. Cancer 2006;106:1857-1862
5. Ooi A, Takehana T, Li X, et al. Protein overexpression and gene amplification of HER-2 and EGFR in colorectal cancers: an immunohistochemical and fluorescent in situ hybridization study. Mod Pathol 2004;17:895-904.
6. Brown KD. The epidermal growth factor/transforming growth factoralpha family and their receptors. Eur J Gastroenterol Hepatol 1995;7: 914-922
7. Sundaresan S, Penuel E, Sliwkowski MX. The biology of human epidermal growth factor receptor 2. Curr Oncol Rep 1999;1:16-22.
8. Roberts RB, Min L, Washington MK, et al. Importance of epidermal growth factor receptor signaling in establishment of adenomas and maintenance of carcinomas during intestinal tumorigenesis. Proc Natl Acad Sci U S A 2002;99:1521-1526
9. Moran AE, Hunt DH, Javid SH, et al. Apc deficiency is associated with increased Egfr activity in the intestinal enterocytes and adenomas of C57BL/6J-Min/+ mice. J Biol Chem 2004;279:43261-43272
10. Corpet DE, Pierre F. Point: from animal models to prevention of colon cancer. Systematic review of chemoprevention in min mice and choice of the model system. Cancer Epidemiol Biomarkers Prev 2003;12:391-400.
11. Edwards BK, Brown ML, Wingo PA, et al. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 2005;97:1407-1427
12. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988;319:525-532
13. Calvert PM, Frucht H. The genetics of colorectal cancer. Ann Intern Med 2002;137:603-612
14. Robbins DH, Itzkowitz SH. The molecular and genetic basis of colon cancer. Med Clin North Am 2002;86:1467-1495
15. O'Brien MJ, Winawer SJ, Zauber AG, et al. The National Polyp Study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology 1990;98:371-379
16. Shimada N, Suzuki J, Fujita J, et al. A comparative study of nucleolar organizer region, proliferating cell nuclear antigen and epidermal growth factor receptor staining in colon tumours. J Gastroenterol Hepatol 1998;13:794-800.
17. Jaszewski R, Levi E, Sochacki P, et al. Expression of epidermal growth factor-receptor related protein (ERRP) in human colorectal carcinogenesis. Cancer Lett 2004;213:249-255
18. Hayashi Y, Widjono YW, Ohta K, et al. Expression of EGF, EGFreceptor, p53, v-erb B and ras p21 in colorectal neoplasms by immunostaining paraffin-embedded tissues. Pathol Int 1994;44:124-130
19. Porebska I, Harlozinska A, Bojarowski T. Expression of the tyrosine kinase activity growth factor receptors (EGFR, ERB B2, ERB B3) in colorectal adenocarcinomas and adenomas. Tumour Biol 2000;21:105-115
20. Moosmann N, Heinemann V. Cetuximab in the treatment of metastatic colorectal cancer. Expert Opin Biol Ther 2007;7:243-256 (Pubitemid 46192172)